Matthew Campbell, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    Bladder Cancer
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    10/15/2027
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    Bladder Cancer
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    10/15/2027
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Exelixis
    Topic:
    Kidney Cancer
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    12/15/2027
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Topic:
    Kidney Cancer
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Eisai
    Topic:
    Kidney Cancer Advisory Board
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    10/24/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    Bladder Cancer Advisory Board
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    06/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    SeaGen
    Topic:
    Bladder Cancer Advisory Board
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    10/24/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Exelixis
    Topic:
    Kidney Cancer Advisory Board
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    10/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Curio Sciences
    Topic:
    Kidney Cancer and Bladder Cancer Education forums
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    10/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Dava Oncology
    Topic:
    Kidney Cancer Education Forum
    Date added:
    10/24/2024
    Date updated:
    10/24/2024
    Relationship end date:
    10/01/2024

Pages

Return to Atlanta Genitourinary Cancers Summit